Evidence map›Paper›PMID 35157458›Full record

ArticleJournal of the American Society for Mass Spectrometry2022

GlycoDeNovo2: An Improved MS/MS-Based

Zizhang Chen, Juan Wei, Yang Tang, Cheng Lin, Catherine E Costello, Pengyu Hong

Abstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zizhang ChenDepartment of Computer Science, Brandeis University, Waltham, Massachusetts 02453, United States.
Juan WeiDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
Yang TangDepartment of Chemistry, Boston University, Boston, Massachusetts 02215, United States.
Cheng LinDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, United States.ORCID https://orcid.org/0000-0003-3653-9633
Catherine E CostelloDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, United States.ORCID https://orcid.org/0000-0003-1594-5122
Pengyu HongDepartment of Computer Science, Brandeis University, Waltham, Massachusetts 02453, United States.

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Legacy Support During Closure of the Mass Spectrometry Resource for Biology and MedicineR24GM134210 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2019 to 2021
$2.1M
High-Throughput De Novo Glycan SequencingR01GM132675 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HONG, PENGYU, LIN, CHENG · 2019 to 2022
$2.0M
A Thermo-Fisher Scientific Orbitrap Fusion Lumos Tribrid Mass Spectrometer SystemS10OD021728 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2018 to 2018
$1.4M
LTQ-FT MS System for On-line Protein and Glycan AnalysisS10RR025082 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2009 to 2009
$1.3M
NCRR NIH HHS S10 RR025082NIGMS NIH HHS R01 GM132675NIGMS NIH HHS R24 GM134210NIH HHS S10 OD021728
6 · The paper itself

Abstract

Glycan structure identification is essential to understanding the roles of glycans in various biological processes. Previously, we developed GlycoDeNovo, a

Indexed as

AlgorithmsGlycopeptidesPolysaccharidesSequence Analysis, ProteinTandem Mass SpectrometryGlycopeptidesPolysaccharidesde novo glycan sequencingMS/MSp-value

Identifiers

PMID35157458
PMCPMC9149727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.